Fluoroquinolone resistance in Mycobacterium tuberculosis: the effect of duration and timing of fluoroquinolone exposure.
AUTHORS
Devasia
RA ,
Blackman
A ,
Gebretsadik
T ,
Griffin
M ,
Shintani
A ,
May
C ,
Smith
T ,
Hooper
N ,
Maruri
F ,
Warkentin
J ,
Mitchel
E ,
Sterling
TR ,
. American journal of respiratory and critical care medicine. 2009 8 15; 180(4). 365-70
- PMID: 19483111 [PubMed].
- PMCID: PMC2731810.
ABSTRACT
Fluoroquinolones are the most commonly prescribed antibiotic class in the United States. They have the potential to become first-line antituberculosis therapy, but the effect of fluoroquinolone use on fluoroquinolone resistance in Mycobacterium tuberculosis is not well characterized.
Fluoroquinolones are the most commonly prescribed antibiotic class in the United States. They have the potential to become first-line antituberculosis therapy, but the effect of fluoroquinolone use on fluoroquinolone resistance in Mycobacterium tuberculosis is not well characterized.
Tags: Alumni Publications 2009